Novartis opens pitch for global brand launch
Novartis, the pharmaceutical giant, is searching for a global advertising agency to handle the international roll-out of an over-the-counter product.
An RFI has been issued to a number of agencies, including UK-based shops, from the Denmark-based intermediary Hestbaek Consult. The brief, dubbed "Project Cool", covers the provision of advertising to support the launch of a product, which is not named in the RFI, across markets in regions including Europe, the US and Asia.
Novartis, which has its headquarters in Basel, Switzerland and has a presence in more than 140 countries, will require the appointed agency to target consumers as well as healthcare professionals.
Agency sources have speculated that the brief relates to a wider roll-out of the Novartis US pain-relief brand Excedrin. They said Excedrin, which spends around $45 million on US advertising, could be set for a global launch that will require a positive brand awareness campaign following a product recall in the US this year.
Novartis works with a number of agencies including DraftFCB London, Wunderman Switzerland and Grey Group.
This article was first published on campaignlive.co.uk
- Mid Weight Planner - ATL Daniel Marks London £30-£50K + Excellent Benefits, Central London
- PPC Executive - Leading Digital Marketing Agency Ultimate Asset £23000 - £28000 per annum + Amazing Benefits, London
- Account Director - FMCG & Retail to £55k Network Career Consultants £48000 - £55000 per annum, City of London
- Account Director - B2B & B2C to £65k Network Career Consultants £55000 - £65000 per annum, City of London
- Senior Brand Consultant - Brand Strategist Royds Raphael £85k-£100k+neg, London
- Cobra introduces bra-making brewer 'The Boss'
- Anti-slavery charity creates '12 Years a Slave' tactical ad after Oscar win
- Majority of 15m Twitter users in the UK follow a newspaper
- Hooch appoints More and MJ Media for Keith Lemon campaign
- Birds Eye kicks off £60m pan-Euro campaign
- OgilvyOne loses BA business